Hepatitis Monthly

Published by: Kowsar

Outcomes of Non-Alcoholic Steatohepatitis Patients After Liver Transplantation: A Systematic Review and Meta-Analysis

Yu Zhao 1 , Xiaoguang Zhan 1 and Yan Zhang 1 , *
Authors Information
1 Surgery Department, Tianjin Second People’s Hospital, Tianjin, China
Article information
  • Hepatitis Monthly: 19 (4); e82336
  • Published Online: April 20, 2019
  • Article Type: Review Article
  • Received: July 18, 2018
  • Revised: March 25, 2019
  • Accepted: April 2, 2019
  • DOI: 10.5812/hepatmon.82336

To Cite: Zhao Y, Zhan X, Zhang Y. Outcomes of Non-Alcoholic Steatohepatitis Patients After Liver Transplantation: A Systematic Review and Meta-Analysis, Hepat Mon. Online ahead of Print ; 19(4):e82336. doi: 10.5812/hepatmon.82336.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Discussion
  • 1. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118(4):1388-93. doi: 10.1542/peds.2006-1212. [PubMed: 17015527].
  • 2. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology. 2011;140(1):124-31. doi: 10.1053/j.gastro.2010.09.038. [PubMed: 20858492].
  • 3. Park SH. Current status of liver disease in Korea: Nonalcoholic fatty liver disease. Korean J Hepatol. 2009;15 Suppl 6:S34-9. doi: 10.3350/kjhep.2009.15.S6.S34. [PubMed: 20037278].
  • 4. Li Z, Xue J, Chen P, Chen L, Yan S, Liu L. Prevalence of nonalcoholic fatty liver disease in mainland of China: A meta-analysis of published studies. J Gastroenterol Hepatol. 2014;29(1):42-51. doi: 10.1111/jgh.12428. [PubMed: 24219010].
  • 5. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7(2):234-8. doi: 10.1016/j.cgh.2008.11.005. [PubMed: 19049831].
  • 6. Wang PX, Ji YX, Zhang XJ, Zhao LP, Yan ZZ, Zhang P, et al. Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates. Nat Med. 2017;23(4):439-49. doi: 10.1038/nm.4290. [PubMed: 28218919].
  • 7. Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant. 2009;9(4):782-93. doi: 10.1111/j.1600-6143.2009.02590.x. [PubMed: 19344467].
  • 8. Cheong J, Galanko JA, Arora S, Cabezas J, Ndugga NJ, Lucey MR, et al. Reduced impact of renal failure on the outcome of patients with alcoholic liver disease undergoing liver transplantation. Liver Int. 2017;37(2):290-8. doi: 10.1111/liv.13182. [PubMed: 27258535]. [PubMed Central: PMC5136341].
  • 9. Barritt A, Dellon ES, Kozlowski T, Gerber DA, Hayashi PH. The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. J Clin Gastroenterol. 2011;45(4):372-8. doi: 10.1097/MCG.0b013e3181eeaff0. [PubMed: 20733515]. [PubMed Central: PMC3292190].
  • 10. Kennedy C, Redden D, Gray S, Eckhoff D, Massoud O, McGuire B, et al. Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases. HPB (Oxford). 2012;14(9):625-34. doi: 10.1111/j.1477-2574.2012.00497.x. [PubMed: 22882200]. [PubMed Central: PMC3461389].
  • 11. Sourianarayanane A, Arikapudi S, McCullough AJ, Humar A. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation. Eur J Gastroenterol Hepatol. 2017;29(4):481-7. doi: 10.1097/MEG.0000000000000820. [PubMed: 28253211].
  • 12. Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012;256(4):624-33. doi: 10.1097/SLA.0b013e31826b4b7e. [PubMed: 22964732].
  • 13. Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009;15(12):1814-20. doi: 10.1002/lt.21927. [PubMed: 19938128].
  • 14. Reddy SK, Steel JL, Chen HW, DeMateo DJ, Cardinal J, Behari J, et al. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology. 2012;55(6):1809-19. doi: 10.1002/hep.25536. [PubMed: 22183968].
  • 15. Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology. 2012;56(5):1741-50. doi: 10.1002/hep.25855. [PubMed: 22611040].
  • 16. Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of liver transplantation for nonalcoholic steatohepatitis: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12(3):394-402 e1. doi: 10.1016/j.cgh.2013.09.023. [PubMed: 24076414].
  • 17. Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation. 2013;95(5):755-60. doi: 10.1097/TP.0b013e31827afb3a. [PubMed: 23370710].
  • 18. Afzali A, Berry K, Ioannou GN. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl. 2012;18(1):29-37. doi: 10.1002/lt.22435. [PubMed: 21932374].
  • 19. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141(4):1249-53. doi: 10.1053/j.gastro.2011.06.061. [PubMed: 21726509].
  • 20. Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl. 2001;7(4):363-73. doi: 10.1053/jlts.2001.23011. [PubMed: 11303298].
  • 21. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: A systematic review of the literature. Diabetes Care. 2002;25(3):583-92. doi: 10.2337/diacare.25.3.583. [PubMed: 11874952].
  • 22. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation. 2007;115(4):459-67. doi: 10.1161/CIRCULATIONAHA.106.628875. [PubMed: 17242284].
  • 23. Lease ED. Infections and sepsis after liver transplantation. In: Doria C, editor. Contemporary liver transplantation. Springer, Cham; 2015. p. 1-13. doi: 10.1007/978-3-319-05543-5_19-1.
  • 24. Van den Berg EH, Douwes RM, de Meijer VE, Schreuder T, Blokzijl H. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity. Dig Liver Dis. 2018;50(1):68-75. doi: 10.1016/j.dld.2017.08.022. [PubMed: 28935188].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments